Douglass C. Hochstetler

Partner

Douglass C. Hochstetler's practice focuses on patent infringement and related antitrust litigation.

He currently is the lead counsel for clients in high-profile cases involving pharmaceutical patents.

Experience

Examples of Mr. Hochstetler's patent infringement litigation experience include (asterisk denotes client):

• Schering v. Geneva Pharmaceuticals* (D. N.J. and Fed. Cir.) (loratadine)
• Elan v. Corepharma* (E.D.N.Y.) (metaxalone)
• Pfizer v. Geneva Pharmaceuticals* (D.N.J.) (gabapentin)
• AstraZeneca v. Lek Pharmaceuticals* (S.D.N.Y.) (omeprazole)
• RCT v. Ben Venue Laboratories* (D.N.J.) (cisplatin)
• Organon v. Geneva Pharmaceuticals*  (D.N.J.) (mirtazapine)
• AHP v. Upjohn Co.* (D.N.J.) (canine vaccine)
• United States Gypsum v. National Gypsum* (N.D. Ill. and Fed. Cir.) (lightweight joint compound)
• McNeil-PPC v. Procter & Gamble* (D. Colo.) (sanitary products)
• Proctor & Gamble* v. Kimberly-Clark (D.S.C.) (disposable diapers)
• LAB, SA v. Chemithon Corp.* (W.D. Wash.) (electrostatic precipitation equipment)
• Oscar Mayer v. Sara Lee* (W.D. Wisc.) (package design)
• Transco Prods.* v. PCI (Fed. Cir.) (nuclear reactor insulation)

Publications

"Patent Litigation Victory!" Schiff Hardin Intellectual Property Update (Winter 2004)

Previous Experience

Mr. Hochstetler joined Schiff Hardin in 2001 after more than 16 years at Marshall, O'Toole, Gerstein, Murray & Borun (Chicago), where he had been a partner since 1990.

Earlier in his legal career, he served in legal and business positions at E.I. du Pont de Nemours & Co. from 1977 to 1985.

Awards and Honors

Leading Lawyer — Intellectual Property Law, Illinois Leading Lawyers Network

Education